Clinical Trials and Research

Neurava Secures $4M NIH Award to Develop AI-Based SUDEP Risk Stratification Algorithm

Funding will support development of a predictive algorithm integrating multimodal physiological data to enable earlier intervention in epilepsy care...

IHH Healthcare delivers strong growth in 2025 and sets clear course towards 2030 with focus on clinical innovation, patient care and environmental stewardship

IHH outlines 2030 sustainability roadmap as it drives clinical excellence, expands capacity, and advances value-based care across global markets...

Everest Medicines Announces Positive First-in-Human Data for Personalised mRNA Cancer Vaccine EVM16 at AACR 2026

Demonstrating a Favourable Safety Profile, Robust Immunogenicity, and Promising Preliminary Efficacy...

Deloitte launches Asia Pacific Health Institute with new report on technology-enabled healthcare access

Deloitte’s new Asia Pacific Health Institute highlights how digital health, AI, and connected care models can address rising demand, workforce pressures, and uneven access across the region...

Vapotherm Secures FDA Clearance for All Patient Circuit to Expand High Velocity Therapy Across Patient Populations

Single disposable circuit enables respiratory support from neonatal to adult patients, simplifying workflows and improving care continuity...

Building a Resilient Surgical Ecosystem in Asia Through Connectivity and Intelligence

Integration of robotics, AI, and advanced connectivity is reshaping surgical ecosystems across Asia Pacific, enabling more precise, scalable, and accessible care...

Datasea Completes $1.01M AI Multimodal Projects to Advance High-Margin Digital Solutions Strategy

Delivery of three projects highlights growing adoption of AI-driven, scenario-based applications across enterprise and digital services...

Genentech Advances Gazyva® for Lupus with FDA Acceptance of New Application

Regulatory milestone expands potential use of anti-CD20 therapy in lupus, building on prior success in lupus nephritis...

Nexalin Technology Advances FDA Strategy for Alzheimer’s Treatment

The FDA provided clinical guidance on the proposed Alzheimer’s symptom reduction FDA clinical trial and regulatory pathway...

Bracco Secures Health Canada Approval for Vueway® to Advance Lower-Dose MRI Contrast Imaging

Gadopiclenol-based contrast agent enables high-quality imaging at reduced gadolinium exposure, supporting safer diagnostic workflows...